Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/12615
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Paiboonvong T. | |
dc.contributor.author | Nosoongnoen W. | |
dc.contributor.author | Sathirakul K. | |
dc.contributor.author | Tangsujaritvijit V. | |
dc.contributor.author | Kaemapairoj J. | |
dc.contributor.author | Tragulpiankit P. | |
dc.contributor.author | Montakantikul P. | |
dc.date.accessioned | 2021-04-05T03:04:26Z | - |
dc.date.available | 2021-04-05T03:04:26Z | - |
dc.date.issued | 2019 | |
dc.identifier.issn | 664804 | |
dc.identifier.other | 2-s2.0-85072588748 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/12615 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072588748&doi=10.1128%2fAAC.00800-19&partnerID=40&md5=62351e29caba94e1451796b151040b0e | |
dc.description.abstract | Sitafloxacin showed potent activity against various respiratory pathogens. Blood and bronchoalveolar lavage (BAL) fluid samples were obtained from 12 subjects after a single oral dose of sitafloxacin 200 mg. The mean ± SD (median) maximum ratio of epithelial lining fluid (ELF) to unbound plasma concentration was 1.02 ± 0.58 (1.33). The penetration ratios based on the mean and median area under the curve from 0 to 8 h (AUC0 – 8) were 0.85 and 0.79 μg · h/ml, respectively. Sitafloxacin penetrates well into ELF in critically ill Thai patients with pneumonia. (This study has been registered in the Thai Clinical Trials Registry [TCTR] under registration no. TCTR20170222001.) Copyright © 2019 American Society for Microbiology. All Rights Reserved. | |
dc.subject | sitafloxacin | |
dc.subject | antiinfective agent | |
dc.subject | quinolone derivative | |
dc.subject | sitafloxacin | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | area under the curve | |
dc.subject | Article | |
dc.subject | blood sampling | |
dc.subject | clinical article | |
dc.subject | critically ill patient | |
dc.subject | drug blood level | |
dc.subject | drug penetration | |
dc.subject | elimination half-life | |
dc.subject | elimination rate constant | |
dc.subject | epithelial lining fluid | |
dc.subject | female | |
dc.subject | human | |
dc.subject | liquid | |
dc.subject | lung lavage fluid | |
dc.subject | male | |
dc.subject | oral clearance | |
dc.subject | pharmacokinetic parameters | |
dc.subject | pneumonia | |
dc.subject | priority journal | |
dc.subject | single drug dose | |
dc.subject | Thai (citizen) | |
dc.subject | time to maximum plasma concentration | |
dc.subject | volume of distribution | |
dc.subject | bronchoalveolar lavage fluid | |
dc.subject | critical illness | |
dc.subject | drug effect | |
dc.subject | lung | |
dc.subject | lung alveolus macrophage | |
dc.subject | lung lavage | |
dc.subject | metabolism | |
dc.subject | microbiology | |
dc.subject | middle aged | |
dc.subject | pneumonia | |
dc.subject | procedures | |
dc.subject | respiratory mucosa | |
dc.subject | Thailand | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Anti-Bacterial Agents | |
dc.subject | Bronchoalveolar Lavage | |
dc.subject | Bronchoalveolar Lavage Fluid | |
dc.subject | Critical Illness | |
dc.subject | Female | |
dc.subject | Fluoroquinolones | |
dc.subject | Humans | |
dc.subject | Lung | |
dc.subject | Macrophages, Alveolar | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Pneumonia | |
dc.subject | Respiratory Mucosa | |
dc.subject | Thailand | |
dc.title | Pharmacokinetics and penetration of sitafloxacin into alveolar epithelial lining fluid in critically ill Thai patients with pneumonia | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Antimicrobial Agents and Chemotherapy. Vol 63, No.10 (2019) | |
dc.identifier.doi | 10.1128/AAC.00800-19 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.